Compagnie Lombard Odier SCmA’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,100
Closed -$4K 638
2022
Q4
$4K Buy
+1,100
New +$121K ﹤0.01% 634
2017
Q4
Sell
-43,600
Closed -$32K 659
2017
Q3
$32K Buy
43,600
+40,000
+1,111% +$707K ﹤0.01% 570
2017
Q2
$2K Buy
+3,600
New +$66.5K ﹤0.01% 693
2016
Q4
Sell
-2,800
Closed -$2K 822
2016
Q3
$2K Buy
+2,800
New +$62.3K ﹤0.01% 888

Other funds holding DXCM

Compagnie Lombard Odier SCmA's DXCM Position: Q2 2026 in Review

Compagnie Lombard Odier SCmA increased its DexCom (DXCM) stake by 2.2% in Q2 2026, buying an estimated $274K and bringing the position to 194,121 shares worth $13.1M. The position accounts for 0.14% of the portfolio, ranked #89.

Compagnie Lombard Odier SCmA first reported a position in DXCM in Q3 2016 and has held it in 40 quarters since. The position peaked at $102M in Q4 2017. 353 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Compagnie Lombard Odier SCmA held 194,121 shares of DexCom worth $13.1M as of Q2 2026.
  • Compagnie Lombard Odier SCmA bought 4,114 DexCom shares in Q2 2026, an estimated $274K.
  • DexCom made up 0.14% of Compagnie Lombard Odier SCmA's portfolio in Q2 2026, its #89 holding.
  • Compagnie Lombard Odier SCmA first reported a position in DexCom in Q3 2016 and has held it in 40 quarters since.
  • Compagnie Lombard Odier SCmA's DexCom position peaked at $102M in Q4 2017.
  • 353 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2026, filed 29 Jul 2026.